Gastric inhibitory peptidereleased by Gastric Inhibitory Peptide: Understanding Its Actions and Significance
Gastric inhibitory peptide (GIP), also known as glucose-dependent insulinotropic polypeptide, is a crucial hormone produced in the upper small intestine. Its primary role is to regulate blood glucose levels by potentiating glucose-stimulated insulin secretion from pancreatic beta cells. Beyond this well-established function, GIP also influences other physiological processes, including gastric acid secretion, glucagon and somatostatin release, and adipocyte biologyEvidence for beneficial effects of compromised gastric .... Understanding the multifaceted gastric inhibitory peptide action is key to appreciating its significance in metabolic health and disease.Severalpeptidesof duodenojejunal origin have been shown to be capable of inhibitinggastricsecretion and motor activity. Secretin, cholecystokinin– ...
Originally identified for its ability to inhibit gastric acid secretion, GIP's most prominent action is its role as an incretin. Incretins are gut hormones released in response to nutrient ingestion, and they enhance insulin secretion in a glucose-dependent manner. This means that GIP primarily stimulates insulin release when blood glucose levels are elevated, thereby preventing excessive post-meal hyperglycemia. This glucose-dependent stimulation is a vital safeguard against dangerously high blood sugar.
While its inhibitory effect on gastric acid secretion is weaker compared to other hormones, it remains a recognized function. This action contributes to the overall regulation of digestion by modulating the rate at which food leaves the stomach and the secretion of digestive acids.
GIP exerts its effects by binding to a specific receptor, the GIP receptor (GIPR), which is a G protein-coupled receptor found on various cell types, including pancreatic beta cells, adipocytes, and even in the central nervous system作者：N Irwin·2009·被引用次数：154—Gastric inhibitory polypeptide (GIP) is a physiological gut peptide secreted from the intestinal K-cells with well documented .... Upon activation, the GIPR triggers intracellular signaling cascades, notably involving adenylate cyclase and cyclic adenosine monophosphate (cAMP), which ultimately mediate the peptide's diverse actions.作者：JJ Meier·2004·被引用次数：207—The insulinotropic gut hormone gastric inhibitory polypeptide (GIP)has been demonstrated to inhibit gastric acid secretionand was proposed to possess ... The presence of GIP receptors in the brain also suggests potential roles in appetite regulation and metabolism beyond its direct effects on the pancreas.
Recent research has illuminated additional actions of GIP, expanding our understanding of its physiological importance. GIP has been shown to stimulate the secretion of glucagon and somatostatin from pancreatic islet cellsGastric inhibitory polypeptide. While glucagon generally raises blood glucose, its secretion in conjunction with insulin release from GIP stimulation can contribute to a balanced metabolic response2025年2月19日—Glucose-dependent insulinotropic polypeptide (GIP)is expressed in pancreatic islet alpha-cellsand promotes insulin secretion.. Furthermore, GIP plays a role in adipocyte biology, influencing fat storage and metabolism.
Emerging evidence also points to non-insulinotropic actions of GIP and GLP-1 (glucagon-like peptide-1), another major incretin hormone. These actions can include effects on pancreatic beta-cell proliferation and survival, suggesting a broader impact on pancreatic health.GIP and GLP‐1, the two incretin hormones - PubMed Central The interplay between GIP and GLP-1 is an active area of research, with both hormones contributing to the regulation of satiety, nausea, and appetite.Its main action isto encourage the release of insulin into the bloodstreamto control blood sugar levels. Glucagon-like peptide 1 Gonadotrophin-releasing ...
The significant role of GIP in glucose homeostasis and metabolism has positioned it as a promising therapeutic target for conditions like type 2 diabetes and obesity.Glucose-Dependent Insulinotropic Polypeptide in Incretin ... Strategies aimed at modulating GIP action, such as blocking its activity to counter insulin resistance or developing dual GIP/GLP-1 receptor agonists, are under investigation. These approaches seek to harness the benefits of incretin signaling for weight management and improved glycemic control. Understanding the intricate gastric inhibitory peptide action provides a foundation for developing innovative treatments for metabolic disorders.
Join the newsletter to receive news, updates, new products and freebies in your inbox.